Everything Health sold CoronaBox as an unapproved COVID-19 drug, FDA and FTC say.
What happened
FDA reviewed the website on February 23, 2021, and FTC reviewed it on May 11, 2021; FDA also reviewed linked social media pages that directed consumers to the site. FDA found CoronaBox offered for sale with claims that it could mitigate, prevent, treat, diagnose, or cure COVID-19. FDA called it an unapproved new drug (a drug sold without FDA approval) and a misbranded drug (labeled or promoted with false or misleading claims).
What FDA found
The company sold CoronaBox as an unapproved new drug (a drug sold without FDA approval) for COVID-19.
section 505(a) of the FD&C Act, 21 U.S.C. § 355(a)The company misbranded CoronaBox by promoting it for COVID-19 uses that FDA has not approved.
section 502 of the FD&C Act, 21 U.S.C. § 352The company introduced or delivered the product into interstate commerce despite these violations.
sections 301(a) and (d) of the FD&C Act, 21 U.S.C. § 331(a) and (d)The company advertised that CoronaBox can prevent, treat, or cure COVID-19 without competent and reliable scientific evidence.
FTC Act, 15 U.S.C. 41 et seq.
What FDA wants
FDA asks the company to take immediate action to stop selling unapproved COVID-19 products and, within 48 hours, email COVID-19-Task-Force-CFSAN@fda.hhs.gov with the steps taken and documents showing prevention of recurrence. FTC separately asks for an email to Richard Cleland at rcleland@ftc.gov within 48 hours describing actions taken.
Who should pay attention
- online sellers of supplement bundles
- companies making COVID-19 health claims
- social media influencers promoting health products
This is a summary. Read the original letter on fda.gov.